We also examined sustained pain freedom and sustained pain relief at 24 hours and found highly significant differences favoring DFN-15.
← all excerpts
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial.
1
—
—